AGRIBIOTECH INC
8-K, 1999-11-16
AGRICULTURAL PRODUCTION-CROPS
Previous: AGRIBIOTECH INC, 8-A12G, 1999-11-16
Next: HEALTHSTAR CORP /UT/, NT 10-Q, 1999-11-16



================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT


                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934




       Date of Report (Date of earliest event reported) November 10, 1999




                              AgriBioTech, Inc.

               (Exact name of issuer as specified in its charter)

           Nevada                      0-19352                  85-0325742
 (State or other jurisdiction of     (Commission           (I.R.S. Employer
  incorporation or organization)      File Number)          Identification No.)


              120 Corporate Park Drive, Henderson, Nevada (89014)
               (Address of principal executive offices) (Zip Code)


       Registrant's telephone number, including area code: (702)566-2440

================================================================================
<PAGE>

Item 5.  Other Events.

     On November 10, 1999, the Board of Directors of AgriBioTech, Inc., a Nevada
corporation  (the  "Company"),  declared  a dividend  distribution  of one right
(each,  a "Right") on each  outstanding  share of the Company's  Common Stock to
shareholders  of record at the close of business on November 24, 1999. One Right
will also be  distributed  for each share of Common Stock issued after  November
24,  1999,  until  the  Distribution  Date  (which  is  described  in  the  next
paragraph).  Each Right  entitles  the  registered  holder to purchase  from the
Company,  upon the occurrence of a Distribution  Date, a unit  consisting of one
one-hundredths of a share (a "Unit") of Series A Junior Participating  Preferred
Stock (the  "Preferred  Stock"),  at a purchase price (the "Purchase  Price") of
$20.00 per Unit, subject to adjustment.  The description and terms of the Rights
are set forth in a Rights  Agreement  dated as of November 11, 1999 (the "Rights
Agreement")  between the Company and Corporate Stock  Transfer,  Inc., as Rights
Agent.

     The Rights Agreement provides that the Company must redeem the Rights (that
is,  terminate  the  Rights  Agreement)  if the  holders  of a  majority  of the
outstanding shares of Common Stock have not approved  continuation of the Rights
Agreement or the use of blank check preferred stock as an  anti-takeover  device
by a vote taken (i) no later than the third annual meeting of stockholders after
November 10, 1999 and (ii) no less  frequently  than every third annual  meeting
thereafter.

     Initially,  the Rights will be attached  to all Common  Stock  certificates
representing  shares then outstanding,  and no separate Rights Certificates will
be  distributed.   The  Rights  will  separate  from  the  Common  Stock  and  a
Distribution  Date will occur upon the earlier of (i) 10 business days following
a public announcement that a person or group of affiliated or associated persons
(an  "Acquiring  Person")  has  acquired,  or  obtained  the  right to  acquire,
beneficial  ownership of 15% or more of the  outstanding  shares of Common Stock
(the "Stock  Acquisition  Date"),  or (ii) 10 business days following the public
announcement  of a tender offer or exchange  offer that would,  if  consummated,
result in a person or group beneficially  owning 15% or more of such outstanding
shares of Common Stock, subject to certain limitations.

     Under the terms of the Rights Agreement,  The State of Wisconsin Investment
Board, which owns approximately 18.9% of the outstanding shares of the Company's
Common Stock, will be permitted to continue to own such shares,  and to increase
its ownership to up to 20% of the  outstanding  shares of Common Stock,  without
becoming an Acquiring Person and triggering a Distribution Date.

     Until the  Distribution  Date (or earlier  redemption  or expiration of the
Rights), (i) the Rights will be evidenced by the Common  Stock certificates  and
will be transferred with and only with such Common Stock certificates,  (ii) new
Common Stock certificates issued after November 24, 1999 will contain a notation
incorporating  the Rights  Agreement by reference  and (iii) the  surrender  for
transfer of any  certificates  for Common Stock  outstanding,  even without such
notation,  will also  constitute the transfer of the Rights  associated with the
Common Stock represented by such  certificate.  As soon as practicable after the
Distribution  Date,  Rights  Certificates will be mailed to holders of record of
the  Common  Stock as of the close of  business  on the  Distribution  Date and,
thereafter,  the separate Rights  Certificates  alone will represent the Rights.
The Rights are not exercisable  until the  Distribution  Date and will expire at
the close of business on November 11, 2009, subject to extension by the Board of
Directors, unless earlier redeemed by the Company as described below.

     In the event that any person becomes an Acquiring Person,  each holder of a
Right will  thereafter have the right (the "Flip-In  Right") to receive,  at the
time  specified in the Rights  Agreement,  (x) upon  exercise and payment of the
Purchase Price,  Common Stock (or, in certain  circumstances,  cash, property or
other  securities of the Company) having a value equal to two times the Purchase
Price or (y) at the  discretion  of the Board of  Directors,  upon  exercise and
without   payment  of  the  Purchase   Price,   Common  Stock  (or,  in  certain
circumstances, cash, property or other securities of the Company) having a value
equal  to the  difference  between  the  Purchase  Price  and the  value  of the
consideration  which would be payable under clause (x).  Notwithstanding  any of
the  foregoing,  following the occurrence of any of the events set forth in this
paragraph, all Rights that are, or (under certain circumstances specified in the
Rights Agreement) were,  beneficially owned by any Acquiring Person will be null
and void.  Flip-In  Rights are not  exercisable  following the occurrence of the
event set forth above until such time as the Rights are no longer  redeemable by
the Company as set forth below.

<PAGE>

     In the event that, at any time  following the Stock  Acquisition  Date, (i)
the Company is acquired in a merger,  statutory share exchange or other business
combination  in which the  Company is not the  surviving  corporation,  (ii) the
Company is the surviving  party in a merger,  statutory  share exchange or other
business  combination and all or part of the Company's Common Stock is exchanged
for stock or other  securities of another  corporation,  or (iii) 50% or more of
the Company's  assets or earning power is sold or transferred,  each holder of a
Right (except Rights which previously have been voided as set forth above) shall
thereafter  have the right (the  "Flip-Over  Right") to receive,  upon exercise,
common stock of the acquiring  corporation having a value equal to two times the
Purchase Price. The holders of a Right will continue to have the Flip-Over Right
whether or not such holder exercises or surrenders the Flip-In Right. The events
set forth in this paragraph and in the second  preceding  paragraph are referred
to as the "Triggering Events."

     The Purchase Price payable,  and the number of Units of Preferred  Stock or
other securities or property  issuable,  upon exercise of the Rights are subject
to adjustment from time to time to prevent  dilution (i) in the event of a stock
dividend on, or a subdivision, combination or reclassification of, the Preferred
Stock,  (ii) if holders of the  Preferred  Stock are granted  certain  rights or
warrants to subscribe for Preferred Stock or convertible securities at less than
the current market price of the Preferred  Stock, or (iii) upon the distribution
to  holders  of the  Preferred  Stock of  evidences  of  indebtedness  or assets
(excluding  regular  quarterly  cash  dividends)  or of  subscription  rights or
warrants (other than those referred to above).  The number of outstanding Rights
and the number of one one-hundredths of a share of Preferred Stock issuable upon
exercise of each Right are also  subject to  adjustment  in the event of a stock
split of the Common  Stock or a stock  dividend on the Common  Stock  payable in
Common Stock or subdivisions, consolidations or combinations of the Common Stock
occurring, in each such case, prior to the Distribution Date.

     With  certain  exceptions,  no  adjustment  in the  Purchase  Price will be
required  until  cumulative  adjustments  amount to at least 1% of the  Purchase
Price. No fractional Units will be issued and, in lieu thereof, an adjustment in
cash will be made based on the market price of the  Preferred  Stock on the last
trading date prior to the date of exercise.

     At any time after any person becomes an Acquiring  Person,  the Company may
exchange  all or part of the Rights for  shares of Common  Stock at an  exchange
ratio of one share per Right,  as  appropriately  adjusted  to reflect any stock
dividend, stock split or similar transaction.

     In general, the Company may redeem the Rights in whole, but not in part, at
a price of $0.001 per Right,  at any time until 10 business  days  following the
Stock Acquisition  Date. After the redemption period has expired,  the Company's
right of  redemption  may be  reinstated  if an  Acquiring  Person  reduces  his
beneficial ownership to less than 15% (or, in the case of The State of Wisconsin
Investment  Board,  20% or less) of the outstanding  shares of Common Stock in a
transaction or series of transactions not involving the Company and there are no
other Acquiring  Persons.  Immediately upon the action of the Board of Directors
ordering  redemption of the Rights, the Rights will terminate and the only right
of the holders of Rights will be to receive the $0.001 redemption price.

     Until a Right is  exercised,  the  holder  thereof,  as such,  will have no
rights as a shareholder of the Company, including, without limitation, the right
to vote or to receive  dividends.  While the distribution of the Rights will not
be taxable to shareholders or to the Company,  shareholders may,  depending upon
the circumstances,  recognize taxable income in the event that the Rights become
exercisable  for stock (or other  consideration)  of the  Company  or for common
stock of the acquiring company as set forth above.

     Prior  to  the  Distribution  Date,  any of the  provisions  of the  Rights
Agreement  may be amended by the Board of Directors  of the  Company.  After the
Distribution  Date, the provisions of the Rights Agreement may be amended by the
Board in order to cure any  ambiguity,  to make changes  which do not  adversely
affect the  interests  of  holders of Rights  (excluding  the  interests  of any
Acquiring  Person),  or to shorten or lengthen  any time period under the Rights
Agreement;  provided,  however,  that no  amendment  to adjust  the time  period
governing redemption shall be made when the Rights are not redeemable.

<PAGE>

     The Company has  initially  authorized  and  reserved  1,000,000  shares of
Preferred  Stock for issuance  upon  exercise of the Rights.  As of November 10,
1999, there were 49,878,281 shares of Common Stock issued and outstanding.

     The Rights may be deemed to have certain  antitakeover  effects. The Rights
generally may cause  substantial  dilution to a person or group that attempts to
acquire the Company under  circumstances  not approved by the Board of Directors
of the Company.

     The Rights  Agreement  between the Company and the Rights Agent  specifying
the terms of the Rights, which includes the Certificate of Designations creating
the  Preferred  Stock,  the Form of the Rights  Certificate  and the  Summary of
Rights  to  Purchase  Shares,  is  attached  as  Exhibit  99.1 to the  Company's
Registration  Statement on Form 8-A filed with the Commission.  The foregoing is
qualified in its entirety by reference thereto.

     The Rights may be deemed to have certain  antitakeover  effects. The Rights
generally may cause  substantial  dilution to a person or group that attempts to
acquire the Company under  circumstances  not approved by the Board of Directors
of the Company.

Item 7. Financial Statements and Exhibits.

     (c)  The following exhibit is filed as a part of this report:

     99.1 Press Release dated  November 12, 1999  announcing the adoption of the
          Rights Agreement.


                                    SIGNATURE

     Pursuant  to the  requirements  of  Section  13 or 15(d) of the  Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereto duly authorized.

Date: November 16, 1999
                                             AGRIBIOTECH, INC.


                                             By: /s/ Randy Ingram
                                                 ----------------
                                                 Randy Ingram
                                                 Executive Vice President and
                                                 Chief Financial Officer



FOR IMMEDIATE RELEASE               November 12, 1999


Contact:
Doug Fisher                                                   Howard Kalt
AgriBioTech, Inc.                                    Kalt Rosen Chase & Co. LLC
702-566-2440                                                  415-397-2686



                AGRIBIOTECH, INC. ADOPTS SHAREHOLDER RIGHTS PLAN


HENDERSON,  NEVADA,  November 12, 1999 - AgriBioTech,  Inc.  (Nasdaq NMS: ABTX),
today  announced  that its Board of  Directors  has  approved  the adoption of a
Shareholder  Rights Plan under which all  shareholders  of record as of November
24, 1999,  will receive  rights to purchase  shares of a new series of Preferred
Stock.

The Rights Plan is designed to enable all  AgriBioTech  shareholders  to realize
the full value of their  investment and to provide for fair and equal  treatment
for  shareholders  in the event that an  unsolicited  attempt is made to acquire
AgriBioTech.  The  adoption  of the Rights  Plan is intended as a means to guard
against  abusive  takeover  tactics  and is not in  response  to any  particular
proposal.

The rights will be distributed as a non-taxable  dividend and will expire in ten
years.  The rights  will be  exercisable  only if a person or group  acquires 15
percent or more of the AgriBioTech  Common Stock or announces a tender offer for
15 percent or more of the Common Stock.

If a person or group acquires 15 percent or more of AgriBioTech's  Common Stock,
all  shareholders  except the purchaser will be entitled to acquire  AgriBioTech
Common  Stock  at a 50  percent  discount.  The  effect  will  be to  discourage
acquisitions  of more  than 15  percent  of  AgriBioTech  Common  Stock  without
negotiations with the Board.

The rights will trade with AgriBioTech's Common Stock, unless and until they are
separated upon the occurrence of certain future events. The rights  distribution
is not taxable to the shareholders.  AgriBioTech's Board of Directors may redeem
the  rights  prior  to  the  expiration  of a  specified  period  following  the
acquisition of more than 15 percent of  AgriBioTech's  Common Stock.  Additional
details  regarding the Rights Plan will be outlined in a summary to be mailed to
all shareholders following the Record Date.

The terms of the Rights  Plan  allow The State of  Wisconsin  Investment  Board,
which owns  approximately  18.9% of AgriBioTech's  Common Stock, to maintain its
investment  in  AgriBioTech,  as well as to acquire  up to 20% of the  Company's
Common Stock, without triggering the rights.

Continuation of the Rights Plan will be subject to shareholder approval no later
than the third annual meeting of stockholders  following the Board's adoption of
the Plan and periodically thereafter.

AgriBioTech is a vertically  integrated,  full service seed company specializing
in the forage and turfgrass seed sector,  complete with research and development
of  proprietary  seed  varieties,  seed  processing  plants,  and a national and
international  distribution and sales network.  AgriBioTech's  vision is to lead
the turf grass and forage seed industry in discovering its potential value.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission